Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 887
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +12.2%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 51–100 of 177 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05056077	Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)(TTBF)	active not recruiting	N/A	353	University of California, San FranciscoOTHER	1	Jun 2, 2026	clinicaltrials
NCT07557225	18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors	recruiting	N/A	200	Peking University First HospitalOTHER	1	May 14, 2026	clinicaltrials